Denali Therapeutics stock price
디날리 테라퓨틱스NASDAQ:DNLI · Nasdaq · Healthcare$20.00-2.58%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Denali Therapeutics last closed at $20.00 (-2.58%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -7.3×. Its overall grade ranks 438 of 739 stocks in Healthcare.
About this company
Denali Therapeutics last closed at $20.00 (-2.58%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B- · 438/739
Valuation grade B
Related stocks
- BiogenCustomer
신경퇴행성 질환 파이프라인에서 공동개발·상업화 파트너로 연결
- TakedaCustomer
희귀질환/신경질환 후보물질의 라이선스·공동개발 파트너
- RocheCustomer
알츠하이머 등 CNS 영역에서 협업 가능성이 큰 대형 제약 파트너
About Denali Therapeutics
- What technical signals does Denali Therapeutics (DNLI) have?
- Denali Therapeutics current technical signals: no active technical signal.
- Is Denali Therapeutics a cup-and-handle pattern?
- No. Denali Therapeutics has no valid Cup signal right now.
- What published figures are available for Denali Therapeutics?
- Market cap: $3.12B. Trailing 12 months PER: -7.3×. Latest quarter PBR: 4.49×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Denali Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy